If you have any evidence that after completion of the P3 trial, NWBO
either verbally or in writing discussed the trial with the FDA,
please be so kind and document this discussion including the
way in which the FDA sent NWBO packing.
Furthermore, IMO the FDA was not in the position to send NWBO
packing because it was the FDA that nixed the trial's control
arm by mandating that all the placebo patients that suffered
a progression, were eligible to start receiving the DCVax-L
treatment. The FDA was therefore in no position to send NWBO
packing.
Bullish
Market Data 
Markets 
AI
